CY1115961T1 - Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) - Google Patents
Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)Info
- Publication number
- CY1115961T1 CY1115961T1 CY20151100093T CY151100093T CY1115961T1 CY 1115961 T1 CY1115961 T1 CY 1115961T1 CY 20151100093 T CY20151100093 T CY 20151100093T CY 151100093 T CY151100093 T CY 151100093T CY 1115961 T1 CY1115961 T1 CY 1115961T1
- Authority
- CY
- Cyprus
- Prior art keywords
- maline
- crystal
- orvepitant maleate
- anhydrated
- anhydrated form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Liquid Crystal Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η εφεύρεση αφορά άνυδρη κρυσταλλική μηλεϊνική ορβεπιτάντη (Μορφή 1), φαρμακευτικά σκευάσματα που περιλαμβάνουν την ίδια, τη χρήση της στη θεραπεία και τις διαδικασίες για την παρασκευή της ίδιας.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0806652.4A GB0806652D0 (en) | 2008-04-11 | 2008-04-11 | Anhydrous crystal form of orvepitant maleate |
| EP09731234.2A EP2297152B1 (en) | 2008-04-11 | 2009-04-09 | Anhydrous crystal form of orvepitant maleate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115961T1 true CY1115961T1 (el) | 2017-01-25 |
Family
ID=39433527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100093T CY1115961T1 (el) | 2008-04-11 | 2015-01-29 | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8309553B2 (el) |
| EP (1) | EP2297152B1 (el) |
| JP (2) | JP5875863B2 (el) |
| KR (1) | KR20110002090A (el) |
| CN (1) | CN102066376B (el) |
| AR (1) | AR071311A1 (el) |
| AU (1) | AU2009235440B2 (el) |
| BR (1) | BRPI0911678B8 (el) |
| CA (1) | CA2721119C (el) |
| CL (1) | CL2009000876A1 (el) |
| CY (1) | CY1115961T1 (el) |
| DK (1) | DK2297152T3 (el) |
| EA (1) | EA017082B1 (el) |
| ES (1) | ES2529295T3 (el) |
| GB (1) | GB0806652D0 (el) |
| HR (1) | HRP20141196T1 (el) |
| IL (1) | IL208597A0 (el) |
| MX (1) | MX2010011152A (el) |
| PE (1) | PE20091839A1 (el) |
| PL (1) | PL2297152T3 (el) |
| PT (1) | PT2297152E (el) |
| RS (1) | RS53732B1 (el) |
| SI (1) | SI2297152T1 (el) |
| TW (1) | TW201002714A (el) |
| UY (1) | UY31758A (el) |
| WO (1) | WO2009124996A1 (el) |
| ZA (1) | ZA201007120B (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8139718B2 (en) * | 2007-10-30 | 2012-03-20 | Elekta Ab (Publ) | Radiotherapy apparatus |
| GB0806652D0 (en) * | 2008-04-11 | 2008-05-14 | Glaxo Group Ltd | Anhydrous crystal form of orvepitant maleate |
| LT2906219T (lt) | 2012-10-11 | 2019-10-25 | Nerre Therapeutics Ltd | Orvepitantas, skirtas lėtinio niežulio gydymui |
| CN108430475B (zh) * | 2016-01-08 | 2021-03-16 | 尼尔医疗有限公司 | 用于治疗慢性咳嗽的奥维匹坦 |
| CN110730662A (zh) | 2017-04-10 | 2020-01-24 | 才思治疗公司 | 用于治疗共核蛋白病的nk1-拮抗剂组合和方法 |
| EA202090180A1 (ru) | 2017-06-30 | 2020-05-26 | Чейс Терапьютикс Корпорейшн | Композиции nk1-антагониста и способы лечения депрессии |
| WO2021198255A1 (en) | 2020-04-03 | 2021-10-07 | Nerre Therapeutics Limited | An nk-1 receptor antagonist for treating a disease selecting from sepsis, septic shock,, acute respiratory distress syndrome (ards) or multiple organ dysfunction syndrome (mods) |
| CN115697332A (zh) | 2020-06-02 | 2023-02-03 | 尼尔医疗有限公司 | 用于治疗由肺的机械损伤促进的肺纤维化状况的神经激肽(nk)-1受体拮抗剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203020D0 (en) * | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| CN101448805B (zh) | 2006-05-22 | 2012-12-12 | Vanda制药公司 | 抑郁障碍的治疗 |
| GB0621229D0 (en) * | 2006-10-20 | 2006-12-06 | Glaxo Group Ltd | Novel use |
| WO2009059324A2 (en) * | 2007-11-02 | 2009-05-07 | Entegris, Inc. | O-ringless seal couplings |
| GB0806652D0 (en) * | 2008-04-11 | 2008-05-14 | Glaxo Group Ltd | Anhydrous crystal form of orvepitant maleate |
-
2008
- 2008-04-11 GB GBGB0806652.4A patent/GB0806652D0/en not_active Ceased
-
2009
- 2009-04-08 PE PE2009000500A patent/PE20091839A1/es not_active Application Discontinuation
- 2009-04-08 AR ARP090101268A patent/AR071311A1/es not_active Application Discontinuation
- 2009-04-09 US US12/936,407 patent/US8309553B2/en active Active
- 2009-04-09 SI SI200931110T patent/SI2297152T1/sl unknown
- 2009-04-09 JP JP2011503450A patent/JP5875863B2/ja active Active
- 2009-04-09 PT PT9731234T patent/PT2297152E/pt unknown
- 2009-04-09 CN CN200980122132.9A patent/CN102066376B/zh active Active
- 2009-04-09 DK DK09731234.2T patent/DK2297152T3/da active
- 2009-04-09 BR BRPI0911678A patent/BRPI0911678B8/pt active IP Right Grant
- 2009-04-09 RS RS20150008A patent/RS53732B1/en unknown
- 2009-04-09 KR KR1020107025211A patent/KR20110002090A/ko active Search and Examination
- 2009-04-09 MX MX2010011152A patent/MX2010011152A/es active IP Right Grant
- 2009-04-09 CA CA2721119A patent/CA2721119C/en active Active
- 2009-04-09 TW TW098111752A patent/TW201002714A/zh unknown
- 2009-04-09 EP EP09731234.2A patent/EP2297152B1/en active Active
- 2009-04-09 WO PCT/EP2009/054295 patent/WO2009124996A1/en active Application Filing
- 2009-04-09 AU AU2009235440A patent/AU2009235440B2/en active Active
- 2009-04-09 CL CL2009000876A patent/CL2009000876A1/es unknown
- 2009-04-09 PL PL09731234T patent/PL2297152T3/pl unknown
- 2009-04-09 EA EA201071183A patent/EA017082B1/ru not_active IP Right Cessation
- 2009-04-09 ES ES09731234.2T patent/ES2529295T3/es active Active
- 2009-04-13 UY UY0001031758A patent/UY31758A/es not_active Application Discontinuation
-
2010
- 2010-10-06 ZA ZA2010/07120A patent/ZA201007120B/en unknown
- 2010-10-10 IL IL208597A patent/IL208597A0/en active IP Right Grant
-
2014
- 2014-06-09 JP JP2014118775A patent/JP2014205688A/ja active Pending
- 2014-12-10 HR HRP20141196AT patent/HRP20141196T1/hr unknown
-
2015
- 2015-01-29 CY CY20151100093T patent/CY1115961T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) | |
| CY1121125T1 (el) | Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης | |
| CY1120318T1 (el) | Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων | |
| CY1118661T1 (el) | Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων | |
| CY1111454T1 (el) | Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων | |
| CY1115199T1 (el) | Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση | |
| ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
| CY1112831T1 (el) | Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh | |
| CY1117326T1 (el) | Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson | |
| TW200605870A (en) | Topical methadone compositions and methods for using the same | |
| MX2009014235A (es) | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
| CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
| DK1962815T3 (da) | Anvendelse af filmdannende hårplejepolymerer fra gruppen polyurethaner og farmaceutiske tilberedninger og plastre indeholdende nævnte polymerer | |
| CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| CY1116840T1 (el) | Χρηση 24-norudca | |
| CL2008002545A1 (es) | Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor. | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
| CY1111361T1 (el) | Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια | |
| UA112981C2 (uk) | Варіант людського gdnf | |
| ATE477820T1 (de) | Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten | |
| CL2008003090A1 (es) | Forma cristalina 1 del etanoato de n-{4-(3-amino-1h-indazol-4-il)fenil}-n'-(2-fluoro-5-metilfenil)urea*1/4; procedimiento de preparacion; composicion farmaceutica que la comprende; utiles en el tratamiento del cancer. |